Condition
Quantitative Analysis of Cisatracurium Infusion Requirements, Sufentanil Consumption and Recovery Index in Different Age Groups.
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Consumption Of Cisatracurium And Sufentanil In Different Age Groups
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Consumption Of Cisatracurium And Sufentanil In Different Age Groups1
- Effect Of Dexmedetomidine On Cisatracurium And Sufentanil Consumption1
Active Sponsors
- Donglai Yan1
- Tianjin Medical University General Hospital1
- Shehzaad Joomye1
- Haiyun Wang1
Top Investigators
Tianjin Medical University General Hospital
Related Conditions
- Effect Of Dexmedetomidine On Sufentanil Consumption1
- The Intraoperative Effect Of Dexmedetomidine On Cisatracurium Infusion Consumption And Its Recovery Index1